Patent Abandoned

RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ

LaoBiz.com profiles the Laos Patent “RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ” from open registry fields, filed by MEDICAGO INC on 2008-07-11; current status: Abandoned. Identifiers include application No. P/120; DIP id LAP120; protection kind Patent - PCT National Phase. Key dates: publication 2025-09-19. Classification: A01H 5/00、A61K 35/76、A61K 39/145、A61P 31/16、A61P 37/04、C07K 14/11、C12N 15/44、C12N 15/82. Inventor(s)/designer(s): Frederic ORS, Louis-Philippe VEZINA, Manon COUTURE, Marc-Andre D'AOUST, Michele DARGIS. Abstract hint: A method for synthesizing influenza virus-like particles (VLPs) within a plant or a portion of a plant is provided. The method involves exp…. Unique application identifiers, holders and classification text are surfaced here to reduce near-duplicate IP landing pages; always verify against the competent office.

Patent Laos DIP

App. no. P/120
Filing date 2008-07-11
Applicant MEDICAGO INC
Agent Lao Trademark Agency
Classes A01H 5/00 · A61K 35/76 · A61K 39/145 · A61P 31/16 · A61P 37/04 · C07K 14/11 · C12N 15/44 · C12N 15/82 · C12N 7/00 · C12N 7/01

Mark

Key facts

Type
Patent
App. no.
P/120
Status
Abandoned
Applicant
MEDICAGO INC
Agent
Lao Trademark Agency
Filing date
2008-07-11
Publication
2025-09-19
Protection kind
Patent - PCT National Phase
Nice / IPC classes
A01H 5/00 · A61K 35/76 · A61K 39/145 · A61P 31/16 · A61P 37/04 · C07K 14/11 · C12N 15/44 · C12N 15/82 · C12N 7/00 · C12N 7/01
Goods / services

Process

Steps follow the current public status
  1. Filed
  2. Formal examination Refused / terminated
  3. Substantive examination
  4. Published
  5. Granted

Related records

Linked from the LaoBiz.com company database

Abstract

A method for synthesizing influenza virus-like particles (VLPs) within a plant or a portion of a plant is provided. The method involves expression of influenza HA in plants and the purification by size exclusion chromatography. The invention is also directed towards a VLP comprising influenza HA protein and plants lipids. The invention is also directed to a nucleic acid encoding influenza HA as well as vectors. The VLPs may be used to formulate influenza vaccines, or may be used to enrich existing vaccines.

LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP120.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP120.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.

提交咨询

留下联系方式,顾问将在工作时间内回复。

联系方式 * 点选后填写 · 至少一种
验证码 *
验证码

确认下单

USD

联系方式 *

本站以美元(USD)计价与结算。请按订单金额汇出 USD;兑换与手续费由汇出方承担,到账不足须补汇。

支付方式

数字交付,无实物运输。下单与付款均在本站完成。

提交后请先预付美元(USD)。未支付可取消。

登录 LaoBiz.com

使用注册邮箱登录您的账号

点击显示验证码 验证码

或使用

使用 Google 登录

还没有账号?

点击显示验证码 验证码

或使用

使用 Google 注册

已有账号?

该社交账号未提供邮箱,请填写常用邮箱并完成验证后即可登录。